| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Cell Growth & Differentiation, Vol 8, Issue 3 311-318, Copyright © 1997 by American Association of Cancer Research
ARTICLES |
A Maity, WG McKenna and RJ Muschel
Department of Radiation Oncology, University of Pennsylvania School of Medicine, Philadelphia 19104, USA.
Progression through the cell cycle in somatic eukaryotic cells is regulated by variations in the levels of cyclin proteins. These protein levels are in turn regulated by cyclical oscillations in their mRNA levels. We show here that regulation of RNA stability plays a role in the mechanisms underlying cell cycle progression. Both cyclin A and B1 messages are expressed at high levels in G2-M and at low levels in early G1. The half-lives of their messages mirror this pattern, long in G2-M (>8 h) and short in early G1 (1-2 h). However, there is evidence of specificity to these changes, because the cyclin A message becomes stable at the G1-S boundary, whereas the cyclin B1 message is unstable until later in S phase. Furthermore, although cyclin B1 mRNA levels are lowered after irradiation because of enhanced instability, cyclin A mRNA levels and message stability are unaffected by irradiation. Additional evidence of specificity was found in an analysis of cyclin E mRNA stability, which remains constant through the cell cycle, although the cyclin E message displays cell cycle-dependent changes in expression. These studies suggest that specific alterations in RNA stability are an important component in regulating the expression of cyclins A and B1 and hence in controlling the cell cycle.
This article has been cited by other articles:
![]() |
K. Horiuchi, M. Umetani, T. Minami, H. Okayama, S. Takada, M. Yamamoto, H. Aburatani, P. C. Reid, D. E. Housman, T. Hamakubo, et al. Wilms' tumor 1-associating protein regulates G2/M transition through stabilization of cyclin A2 mRNA PNAS, November 14, 2006; 103(46): 17278 - 17283. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kishore, I. Spyridopoulos, C. Luedemann, and D. W. Losordo Functionally Novel Tumor Necrosis Factor-{alpha}-Modulated CHR-Binding Protein Mediates Cyclin A Transcriptional Repression in Vascular Endothelial Cells Circ. Res., August 23, 2002; 91(4): 307 - 314. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Chen, M. Hunter-Ensor, P. Schotland, and A. Sehgal Alterations of per RNA in Noncoding Regions Affect Periodicity of Circadian Behavioral Rhythms J Biol Rhythms, October 1, 1998; 13(5): 364 - 379. [Abstract] [PDF] |
||||
![]() |
U Atasoy, J Watson, D Patel, and J. Keene ELAV protein HuA (HuR) can redistribute between nucleus and cytoplasm and is upregulated during serum stimulation and T cell activation J. Cell Sci., January 11, 1998; 111(21): 3145 - 3156. [Abstract] [PDF] |
||||
![]() |
N. Detich, S. Ramchandani, and M. Szyf A Conserved 3'-Untranslated Element Mediates Growth Regulation of DNA Methyltransferase 1 and Inhibits Its Transforming Activity J. Biol. Chem., June 29, 2001; 276(27): 24881 - 24890. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Sanchez and J. J. Moreno Role of EP1 and EP4 PGE2 subtype receptors in serum-induced 3T6 fibroblast cycle progression and proliferation Am J Physiol Cell Physiol, February 1, 2002; 282(2): C280 - C288. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |